Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 15.18 % |
3 Month Return | + 46.05 % |
1 Year Return | + 154.49 % |
Market Stats | |
Previous Close | ₹4.25 |
Open | ₹4.26 |
Volume | 66.21L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹603.64Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹603.64 Cr |
P/B Ratio | 1.28 |
EPS | 0.01 |
Dividend Yield | 0 |
Sector | Trading |
ROE | 2.53 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹603.64 Cr | -8.01% | 0.94 | ₹1 Cr | ₹69 Cr | |
NA | ₹16.10 Cr | -4.78% | 0.50 | NA | NA | |
NA | ₹335.18 Cr | 37.47% | 0.75 | ₹27 Cr | ₹2,117 Cr | |
NA | ₹90.96 Cr | 15.97% | 0.50 | -₹1 Cr | ₹4 Cr | |
NA | ₹33.40 Cr | 0.27% | 0.74 | NA | NA |
Organisation | Evexia Lifecare Ltd |
Headquarters | Ahmedabad |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Evexia Lifecare Ltd
Evexia Lifecare has acquired a 51% stake in Vittals MediCare for Rs 35 crores, enhancing its global footprint in the diagnostics sector. The stock has shown significant gains, marking a 120% increase year-to-date and hitting an upper circuit recently.
Evexia Lifecare Expands into Diagnostics Market - 08 Oct, 2024
Evexia Lifecare is acquiring a 51% stake in Vittals MediCare for Rs 35 crores, marking its entry into the diagnostics sector. Additionally, its subsidiary will invest Rs 190 crores to control a healthcare group in the UAE, enhancing its global footprint.
Evexia Lifecare Stock Reaches New High After Fundraising - 01 Oct, 2024
Evexia Lifecare's stock hit a 52-week high of Rs 4, rising 4.17% following a fundraising announcement. The stock has surged 150% from its low and delivered substantial annual returns of 110.53%. The board approved a preferential issue of convertible warrants worth Rs 86.4 crore, contributing to strong net sales growth of 45.65% due to increased demand for healthcare services.
Evexia Lifecare Ltd Sees Stock Surge on Positive Developments - 26 Sep, 2024
Evexia Lifecare Ltd's share price rose by 1.86% following an agreement for convertible warrants issuance. The company reported significant growth in net sales and profit, reflecting strong investor interest and optimism about its biopharmaceutical prospects.
Evexia Lifecare Plans Major Fundraising Initiative - 23 Sep, 2024
Evexia Lifecare's board approved a preferential issue of 24 crore convertible warrants at ₹3.60 each, potentially raising ₹86.4 crore. The stock reached a 52-week high, reflecting strong market interest and significant returns over the past year.
Evexia Lifecare Plans Fundraising, Shares Surge - 11 Sep, 2024
Evexia Lifecare is set to hold a board meeting on September 16 to discuss fundraising through equity warrants. Shares rose 1.5% following the announcement, reflecting positive market sentiment amid strong financial performance.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.03% to 1.49% in Sep 2024 quarter
Best in 1 Year
In the last 1 year, Evexia Lifecare has outperformed top 5 stocks with highest market-cap in Commodity Chemicals
Against Peers
In the last 3 years, Solar Industries India Ltd has given 356.3% return, outperforming this stock by 395.4%
Price Dip
In the last 3 years, Evexia Lifecare stock has moved down by -39.0%
Retail Holding Down
Retail Investor have decreased holdings from 92.50% to 92.47% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 2.73 Cr → 0.24 Cr (in ₹), with an average decrease of 91.2% per quarter
Promoter Holding Down
Promoters have decreased holdings from 6.29% to 5.87% in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 25.58 Cr → 21.36 Cr (in ₹), with an average decrease of 16.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 5.87% | ||
Foreign Institutions | 1.49% | 45.48 | |
Mutual Funds | 0.04% | ||
Retail Investors | 92.47% | ||
Others | 0.13% |
Evexia Lifecare Ltd’s net profit jumped 9.09% since last year same period to ₹0.24Cr in the Q1 2024-2025. On a quarterly growth basis, Evexia Lifecare Ltd has generated -91.21% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Evexia Lifecare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Evexia Lifecare Ltd (524444) share price today is ₹4.14
Evexia Lifecare Ltd is not listed on NSE
Evexia Lifecare Ltd is listed on BSE
Today’s traded volume of Evexia Lifecare Ltd(524444) is 66.21L.
Today’s market capitalisation of Evexia Lifecare Ltd(524444) is ₹603.64Cr.
Evexia Lifecare Ltd(524444 | Price |
---|---|
52 Week High | ₹4.34 |
52 Week Low | ₹1.55 |
Evexia Lifecare Ltd(524444) share price is ₹4.14. It is down -4.61% from its 52 Week High price of ₹4.34
Evexia Lifecare Ltd(524444) share price is ₹4.14. It is up 167.10% from its 52 Week Low price of ₹1.55
Evexia Lifecare Ltd(524444 | Returns |
---|---|
1 Day Returns | -0.11% |
1 Month Returns | 15.18% |
3 Month Returns | 46.05% |
1 Year Returns | 154.49% |